ASH 2009: Joan Bladé
Thalidomide/Dexamethasone (TD) Vs. Bortezomib (Velcade®)/Thalidomide/Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade® as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial
Joan Bladé, MD
Hospital Clinic
Barcelona, Spain
12.15.09
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
button next to the volume control in the
lower right hand corner.
print
related articles